Td Asset Management Inc Global Blood Therapeutics, Inc. Transaction History

Td Asset Management Inc

$107 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 04, 2022	SELL	$22.3 - $37.39 $170,951 - $286,631	-7,666 Reduced 10.58%	64,808 $2.07 Million
Q1 2022 May 10, 2022	SELL	$25.68 - $35.59 $824,636 - $1.14 Million	-32,112 Reduced 30.7%	72,474 $2.51 Million
Q4 2021 Feb 10, 2022	BUY	$24.9 - $40.26 $859,348 - $1.39 Million	34,512 Added 49.25%	104,586 $3.06 Million
Q2 2021 Aug 11, 2021	SELL	$32.46 - $43.42 $479,823 - $641,834	-14,782 Reduced 17.42%	70,074 $1.92 Million
Q1 2021 May 14, 2021	BUY	$38.94 - $50.85 $119,545 - $156,109	3,070 Added 3.75%	84,856 $3.46 Million
Q4 2020 Feb 16, 2021	SELL	$37.65 - $63.77 $83,771 - $141,888	-2,225 Reduced 2.65%	81,786 $3.54 Million
Q3 2020 Nov 10, 2020	SELL	$52.76 - $74.49 $512,668 - $723,819	-9,717 Reduced 10.37%	84,011 $4.63 Million
Q2 2020 Aug 13, 2020	SELL	$48.73 - $81.82 $236,535 - $397,154	-4,854 Reduced 4.92%	93,728 $5.92 Million
Q1 2020 May 15, 2020	SELL	$41.72 - $87.2 $419,160 - $876,098	-10,047 Reduced 9.25%	98,582 $5.04 Million
Q4 2019 Feb 11, 2020	BUY	$45.7 - $81.86 $1.14 Million - $2.04 Million	24,900 Added 29.74%	108,629 $8.64 Million
Q3 2019 Nov 07, 2019	BUY	$45.35 - $57.91 $350,918 - $448,107	7,738 Added 10.18%	83,729 $4.06 Million
Q2 2019 Aug 01, 2019	BUY	$52.6 - $63.29 $552,089 - $664,291	10,496 Added 16.03%	75,991 $4 Million
Q1 2019 May 08, 2019	BUY	$39.99 - $53.48 $135,966 - $181,832	3,400 Added 5.48%	65,495 $3.47 Million
Q4 2018 Feb 01, 2019	BUY	$31.54 - $46.67 $19,996 - $29,588	634 Added 1.03%	62,095 $2.55 Million
Q3 2018 Nov 01, 2018	BUY	$38.0 - $51.1 $410,400 - $551,880	10,800 Added 21.32%	61,461 $2.34 Million
Q2 2018 Jul 31, 2018	BUY	$38.7 - $50.15 $100,620 - $130,390	2,600 Added 5.41%	50,661 $2.29 Million
Q1 2018 May 11, 2018	BUY	$39.6 - $65.9 $553,845 - $921,677	13,986 Added 41.04%	48,061 $2.32 Million
Q4 2017 Feb 02, 2018	BUY	$29.7 - $45.7 $1.01 Million - $1.56 Million	34,075	34,075 $1.34 Million

Others Institutions Holding GBT

# of Institutions

Shares Held

288K

Call Options Held

Put Options Held

View Full List

About Global Blood Therapeutics, Inc.

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

More about GBT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Td Asset Management Inc with notifications on news.

Account